Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Accumulated Expenses: 2020-2025

Historic Accumulated Expenses for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to $10,494.

  • Molecular Partners Ag's Accumulated Expenses rose 1382.41% to $10,494 in Q3 2025 from the same period last year, while for Sep 2025 it was $10,494, marking a year-over-year increase of 1382.41%. This contributed to the annual value of $8.8 million for FY2024, which is 4.28% up from last year.
  • As of Q3 2025, Molecular Partners Ag's Accumulated Expenses stood at $10,494, which was down 10.47% from $11,721 recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Accumulated Expenses high stood at $10.8 million for Q4 2021, and its period low was -$1.8 million during Q2 2023.
  • Over the past 3 years, Molecular Partners Ag's median Accumulated Expenses value was -$567.21 (recorded in 2023), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Molecular Partners Ag's Accumulated Expenses tumbled by 22,917.73% in 2023, and later surged by 1,382.41% in 2025.
  • Molecular Partners Ag's Accumulated Expenses (Quarterly) stood at $10.8 million in 2021, then decreased by 28.02% to $7.8 million in 2022, then rose by 9.27% to $8.5 million in 2023, then increased by 3.43% to $8.8 million in 2024, then soared by 1,382.41% to $10,494 in 2025.
  • Its Accumulated Expenses stands at $10,494 for Q3 2025, versus $11,721 for Q2 2025 and $5,949 for Q1 2025.